Inari Raises FY24 Revenue From $594.5M-$604.5M To $601.5M-$604.5M Vs $600.183M Est
Portfolio Pulse from Benzinga Newsdesk
Inari Medical has raised its fiscal year 2024 revenue guidance to a range of $601.5 million to $604.5 million, up from the previous range of $594.5 million to $604.5 million. This new guidance is slightly above the consensus estimate of $600.183 million.
October 28, 2024 | 8:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Inari Medical has increased its FY24 revenue guidance, indicating a positive outlook for the company's financial performance. The new guidance is slightly above market expectations.
The increase in revenue guidance suggests that Inari Medical is experiencing better-than-expected business conditions, which is a positive indicator for the company's future performance. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100